Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Environ Sci Technol Lett ; 9(6): 543-550, 2022 Jun 14.
Article in English | MEDLINE | ID: mdl-35719858

ABSTRACT

An end goal of fecal source tracking (FST) is to provide information on risk of transmission of waterborne illnesses associated with fecal contamination. Ideally, concentrations of FST markers in ambient waters would reflect exposure risk. Human mtDNA is an FST marker that is exclusively human in origin and may be elevated in feces of individuals experiencing gastrointestinal inflammation. In this study, we examined whether human mtDNA is elevated in fecal samples from individuals with symptomatic norovirus infections using samples from the United States (US), Mozambique, and Bangladesh. We quantified hCYTB484 (human mtDNA) and HF183/BacR287 (human-associated Bacteroides) FST markers using droplet digital polymerase chain reaction. We observed the greatest difference in concentrations of hCYTB484 when comparing samples from individuals with symptomatic norovirus infections versus individuals without norovirus infections or diarrhea symptoms: log10 increase of 1.42 in US samples (3,820% increase, p-value = 0.062), 0.49 in Mozambique (308% increase, p-value = 0.061), and 0.86 in Bangladesh (648% increase, p-value = 0.035). We did not observe any trends in concentrations of HF183/BacR287 in the same samples. These results suggest concentrations of fecal mtDNA may increase during symptomatic norovirus infection and that mtDNA in environmental samples may represent an unambiguously human source-tracking marker that correlates with enteric pathogen exposure risk.

2.
J Pediatr Gastroenterol Nutr ; 64(2): 180-185, 2017 02.
Article in English | MEDLINE | ID: mdl-27632431

ABSTRACT

The development of sustainable intestinal organoid cell culture has emerged as a new modality for the study of intestinal function and cellular processes. Organoid culture is providing a new testbed for therapeutic research and development. Intestinal organoids, self-renewing 3-dimensional structures comprised intestinal stem cells and their differentiated epithelial progeny allow for more facile and robust exploration of cellular activity, cell organization and structure, genetic manipulation, and vastly more physiologic modeling of intestinal response to stimuli as compared to traditional 2-dimensional cell line cultures. Intestinal organoids are affecting a wide variety of research into gastrointestinal pathology. The purpose of this review is to discuss the current state-of-the-art and future effect of research using enteroids and colonoids (organoids grown from the small and large intestines, respectively).


Subject(s)
Biomedical Research/methods , Intestinal Diseases , Organoids , Animals , Cystic Fibrosis/genetics , Cystic Fibrosis/microbiology , Cystic Fibrosis/physiopathology , Cystic Fibrosis/therapy , Humans , Infections/genetics , Infections/microbiology , Infections/physiopathology , Infections/therapy , Intestinal Diseases/genetics , Intestinal Diseases/microbiology , Intestinal Diseases/physiopathology , Intestinal Diseases/therapy , Intestinal Neoplasms/genetics , Intestinal Neoplasms/microbiology , Intestinal Neoplasms/physiopathology , Intestinal Neoplasms/therapy , Models, Biological , Organoids/microbiology , Organoids/physiology , Organoids/physiopathology , Precision Medicine/methods , Tissue Engineering/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...